GALT
Galectin Therapeutics Inc
3.60$
+0.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 11.3% | – | – | – | 27.8% | – | – | – | – | – | – | – | |
| – | -11.3% | – | – | – | -27.8% | – | – | – | – | – | – | – | |
| – | 10,285.0% | – | – | – | 30,858.3% | – | – | – | – | – | – | – | |
| – | 1,666.3% | – | – | – | 3,663.9% | – | – | – | – | – | – | – | |
| – | 11,951.3% | – | – | – | 34,522.2% | – | – | – | – | – | – | – | |
| – | -11,951.3% | – | – | – | -34,522.2% | – | – | – | – | – | – | – | |
| – | 1,058.8% | – | – | – | 4,791.7% | – | – | – | – | – | – | – | |
| – | -12,496.3% | – | – | – | -33,241.7% | – | – | – | – | – | – | – | |
| – | -2,837.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12,496.3% | – | – | – | -33,241.7% | – | – | – | – | – | – | – | |
| – | -11,426.3% | – | – | – | -28,422.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.